The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Covidien Public Limited Company

NYSE: COV
Last

(U.S.) $108.07

Today's change+1.62 +1.52%
Updated January 23 4:01 PM EST. Delayed by at least 15 minutes.
 

Covidien Public Limited Company

NYSE: COV
Last

(U.S.) $108.07

Today's change+1.62 +1.52%
Updated January 23 4:01 PM EST. Delayed by at least 15 minutes.

Covidien Public Limited Company Hits New 52-week High

Covidien Public Limited Company closed up sharply Friday, rallying (U.S.)$1.62 or 1.52% to (U.S.)$108.07 and setting a new 52-week high. Over the last five days, shares have gained 3.86% and outperformed the S&P 500 index over the last 52 weeks with a 60.96% increase in price.

Key company metrics

  • Open(U.S.) $106.85
  • Previous close(U.S.) $106.45
  • High(U.S.) $108.57
  • Low(U.S.) $106.72
  • Bid / Ask-- / --
  • YTD % change+5.66%
  • Volume8,351,790
  • Average volume (10-day)4,385,898
  • Average volume (1-month)3,990,804
  • Average volume (3-month)3,448,119
  • 52-week range(U.S.) $65.97 to (U.S.) $108.57
  • Beta1.04
  • Trailing P/E27.76×
  • P/E 1 year forward24.95×
  • Forward PEG3.12×
  • Indicated annual dividend(U.S.) $1.44
  • Dividend yield1.33%
  • Trailing EPS(U.S.) $3.89
Updated January 23 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+16.58%

Based on its net profit margin of 16.58%, Covidien Public Limited Company is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 26, 201412/26/2014Sep 26, 201409/26/2014Jun 27, 201406/27/2014Mar 28, 201403/28/2014
Revenue2,6862,7342,6882,598
Total other revenue--------
Total revenue2,6862,7342,6882,598
Gross profit1,6441,6621,5841,518
Total cost of revenue1,0421,0721,1041,080
Total operating expense2,0492,2212,3222,016
Selling / general / administrative8658801,030895
Research & development133149137135
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)912347-95
Other operating expenses, total--------
Operating income637513366582
Interest income (expense), net non-operating-48-49-48-54
Gain (loss) on sale of assets--------
Other--------
Income before tax583401308601
Income after tax511517306441
Income tax, total72-1162160
Net income511517306441
Total adjustments to net income--------
Net income before extra. items511517306441
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items511517306441
Inc. avail. to common incl. extra. items511517306441
Diluted net income511520306441
Dilution adjustment--3----
Diluted weighted average shares458459455454
Diluted EPS excluding extraordinary itemsvalue per share1.121.130.670.97
Dividends per sharevalue per share0.360.680.000.64
Diluted normalized EPSvalue per share1.131.310.780.82